Table 1.
Clinicopathological characteristics and lymph node status of patients with cervical cancer.
| Characteristics | Total | Non-LNM | LNM | p | |
|---|---|---|---|---|---|
| No. of Patients | 61 | 44 | 17 | ||
| Age (years) a | 51 ± 12 (28–78) | 50 ± 12 (28–78) | 52 ± 12 (29–70) | 0.513 | |
| Tumor size (mm) a | 36 ± 21 (13–105) | 31 ± 17 (15–72) | 44 ± 19 (13–105) | 0.009 | |
| Menopausal status | 0.437 * | ||||
| No | 30 (49.2) | 23 (52.3) | 7 (41.2) | ||
| Yes | 31 (50.8) | 21 (47.7) | 10 (58.8) | ||
| Histological classification | 0.423 * | ||||
| CSC | 52 (85.2) | 36 (81.8) | 16 (94.1) | ||
| CA | 9 (14.8) | 8 (18.2) | 1 (5.9) | ||
| FIGO stage | <0.001 * | ||||
| Early stage (IB-IIA) | 32 (52.5) | 31 (70.5) | 1 (5.9) | ||
| Advanced stage (IIB-IV) | 29 (47.5) | 13 (29.5) | 16 (94.1) | ||
| Histologic grade | 0.009 * | ||||
| Low grade | 32 (52.5) | 28 (63.6) | 4 (23.5) | ||
| High grade | 29 (47.5) | 16 (36.4) | 13 (76.5) | ||
| Depth of invasion | <0.001 * | ||||
| <2/3 of cervical wall | 27 (44.3) | 26 (59.1) | 1 (5.9) | ||
| ≥2/3 of cervical wall | 34 (55.7) | 18 (40.9) | 16 (94.1) | ||
| SCC-Ag level | 0.133 * | ||||
| ≤1.5 ng/mL | 21 (34.4) | 18 (40.9) | 3 (17.6) | ||
| >1.5 ng/mL | 40 (65.6) | 26 (59.1) | 14 (82.4) | ||
| Vascular invasion | 0.421 * | ||||
| No | 44 (72.1) | 33 (75.0) | 11 (64.7) | ||
| Yes | 17 (27.9) | 11 (25.0) | 6 (35.3) | ||
a Numbers are means ± standard deviations with ranges in parentheses; other data are presented as n (%). * Chi-square test used. The bold font in the table indicates the comparison with statistical significance. LNM = lymph node metastasis; Non-LNM = non-lymph node metastasis; CSC = cervical squamous carcinoma; CA = cervical adenocarcinoma; FIGO = International Federation of Gynecology and Obstetrics; SCC-Ag = squamous cell carcinoma antigen.